Filing Details

Accession Number:
0001209191-23-006465
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-02 21:00:12
Reporting Period:
2023-01-31
Accepted Time:
2023-02-02 21:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185191 T James Treace C/O Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra FL 32081
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-31 11,929 $23.19 1,011,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 556,183 Indirect By Spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.8000 to $23.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.